Ligand · CH0
CH0 · 2-{[(3alpha,5alpha,7alpha,8alpha,10alpha,12alpha,17alpha)-3,12-bis{2-[(4-O-alpha-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]ethoxy}cholan-7-yl]oxy}ethyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside
CH0, 2-{[(3alpha,5alpha,7alpha,8alpha,10alpha,12alpha,17alpha)-3,12-bis{2-[(4-O-alpha-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]ethoxy}cholan-7-yl]oxy}ethyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside (C66 H114 O36, 1483.6 g/mol)…
- Component
- CH0
- Formula
- C66 H114 O36
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CH0 in 2 structures; the first of them:
- 3KW4 · Crystal structure of cytochrome 2B4 in complex with the anti-platelet drug ticlopidine · CH0 A603 · binds VAL39, LEU43, ARG48, SER211, PHE212, SER213, VAL216, PHE220 and 3 more
- 3KW4 · Crystal structure of cytochrome 2B4 in complex with the anti-platelet drug ticlopidine · CH0 A603 · binds VAL39, LEU43, ARG48, SER211, PHE212, SER213, VAL216, PHE220 and 3 more
Residues it binds most
PHE 2, LEU 2, SER 2, VAL 2, ARG 2, GLU 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.